Celcuity Inc. Common Stock (CELC) Stock
NASDAQ · CELC
84.00
Fundamentals
Market cap
$3.94B
Price / Earnings ratio
-17.4x
Price / Sales ratio
N/A
Price / Book ratio
-308.6x
Return on assets
-0.5%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About Celcuity Inc. Common Stock
No description available.
SectorHealthcare
IndustryBiotechnology
Employees155
CEOMr. Brian F. Sullivan
IPO DateSep 19, 2017
HeadquartersMinneapolis, MN
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Brian F. Sullivan | Co-Founder, Chairman & CEO | 1962 |
| Dr. Lance G. Laing Ph.D. | Co-Founder, Chief Science Officer, VP, Secretary & Director | 1962 |
| Ms. Vicky Hahne CPA | Chief Financial Officer | 1966 |
| Ms. Jodi Sievers | Head of Investor Relations & Corporate Communications | — |
| Mr. Brent Eilefson | General Counsel | — |
| Ms. Sheri Smith | Acting Head of Clinical Operations | — |
| Mr. Igor Gorbatchevsky M.D. | Chief Medical Officer | — |
| Mr. Eldon C. Mayer III, M.B.A. | Chief Commercial Officer | 1961 |
Fundamentals
Valuation
Market cap$3.94B
Price-to-sales ratioN/A
Price-to-book value-308.61
Price-earnings ratio-17.40
Return on Equity-245.00%
Return on SalesN/A
Return on AssetsN/A
PEG ratioN/A
Earnings Per Share
Earnings Per Share$-4.31
Income Statement
Average volume840,314
EBITDA$-172.67M
1 year high (52w)$151.02
1 year low (52w)$44.42
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



